Foreword

Stanley H. Appel

doi:10.1007/978-3-319-08046-8

Foreword

Research output: Chapter in Book/Report/Conference proceeding › Foreword/postscript

Abstract

Parkinson’s Disease (PD) is a progressive neurodegenerative disease with a prevalence of 0.1% of the global population, and 5-10% patients are under 40 years of age. Several text books have been published on various aspects of PD to date, including research and clinical aspects. However these do not emphasize the inflammatory pathways and pathways of neurodegeneration in PD. Inflammation in Parkinson’s Disease brings advances in research together with current literature and evidence. This concise volume covers the fundamentals of neuroimmunology and inflammatory models, the interactions between pathways of neurodegeneration and follows the concept of research work undertaken from basic science to clinical trials. Researchers, clinicians, and students interested in Parkinson's Disease are provided with a comprehensive view of translational research methods and an insight needed for developing future therapies aimed at disease modulation.

Original language	English (US)
Title of host publication	Inflammation in Parkinson's Disease
Subtitle of host publication	Scientific and Clinical Aspects
Editors	Madhavi Thomas
Publisher	Springer US
Pages	vii-x
Number of pages	4
Edition	1
ISBN (Electronic)	978-3-319-08046-8
ISBN (Print)	978-3-319-08045-1
DOIs	https://doi.org/10.1007/978-3-319-08046-8
State	Published - May 1 2014

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-3-319-08046-8

Cite this

@inbook{2b918c9b0c2e49e5a661698b13333468,

title = "Foreword",

abstract = "Parkinson{\textquoteright}s Disease (PD) is a progressive neurodegenerative disease with a prevalence of 0.1% of the global population, and 5-10% patients are under 40 years of age. Several text books have been published on various aspects of PD to date, including research and clinical aspects. However these do not emphasize the inflammatory pathways and pathways of neurodegeneration in PD. Inflammation in Parkinson{\textquoteright}s Disease brings advances in research together with current literature and evidence. This concise volume covers the fundamentals of neuroimmunology and inflammatory models, the interactions between pathways of neurodegeneration and follows the concept of research work undertaken from basic science to clinical trials. Researchers, clinicians, and students interested in Parkinson's Disease are provided with a comprehensive view of translational research methods and an insight needed for developing future therapies aimed at disease modulation.",

author = "Appel, {Stanley H.}",

year = "2014",

month = may,

day = "1",

doi = "10.1007/978-3-319-08046-8",

language = "English (US)",

isbn = "978-3-319-08045-1",

pages = "vii--x",

editor = "Madhavi Thomas",

booktitle = "Inflammation in Parkinson's Disease",

publisher = "Springer US",

address = "United States",

edition = "1",

}

TY - CHAP

T1 - Foreword

AU - Appel, Stanley H.

PY - 2014/5/1

Y1 - 2014/5/1

N2 - Parkinson’s Disease (PD) is a progressive neurodegenerative disease with a prevalence of 0.1% of the global population, and 5-10% patients are under 40 years of age. Several text books have been published on various aspects of PD to date, including research and clinical aspects. However these do not emphasize the inflammatory pathways and pathways of neurodegeneration in PD. Inflammation in Parkinson’s Disease brings advances in research together with current literature and evidence. This concise volume covers the fundamentals of neuroimmunology and inflammatory models, the interactions between pathways of neurodegeneration and follows the concept of research work undertaken from basic science to clinical trials. Researchers, clinicians, and students interested in Parkinson's Disease are provided with a comprehensive view of translational research methods and an insight needed for developing future therapies aimed at disease modulation.

AB - Parkinson’s Disease (PD) is a progressive neurodegenerative disease with a prevalence of 0.1% of the global population, and 5-10% patients are under 40 years of age. Several text books have been published on various aspects of PD to date, including research and clinical aspects. However these do not emphasize the inflammatory pathways and pathways of neurodegeneration in PD. Inflammation in Parkinson’s Disease brings advances in research together with current literature and evidence. This concise volume covers the fundamentals of neuroimmunology and inflammatory models, the interactions between pathways of neurodegeneration and follows the concept of research work undertaken from basic science to clinical trials. Researchers, clinicians, and students interested in Parkinson's Disease are provided with a comprehensive view of translational research methods and an insight needed for developing future therapies aimed at disease modulation.

UR - http://www.scopus.com/inward/record.url?scp=84930882373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930882373&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-08046-8

DO - 10.1007/978-3-319-08046-8

M3 - Foreword/postscript

AN - SCOPUS:84930882373

SN - 978-3-319-08045-1

SP - vii-x

BT - Inflammation in Parkinson's Disease

A2 - Thomas, Madhavi

PB - Springer US

ER -

Foreword

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this